{
  "main_header": {
    "sid": 770569,
    "name": "Medicamen Biotec",
    "stock_name": "Medicamen Biotec",
    "full_name": "Medicamen Biotech Ltd",
    "name_url": "stocks-analysis/medicamen-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "222.30",
    "chg": -2.15,
    "chgp": "-0.96%",
    "dir": -1,
    "prev_price": "224.45",
    "mcapval": "304.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531146,
    "symbol": "MEDICAMEQ",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE646B01010",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "24.39 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/medicamen-biotec-770569-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 6202,
    "sid": "770569",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/medicamen-biotech-770569"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-May-2026",
      "details": "Announcement under Regulation 30 (LODR) - Newspaper Publication for BM held on 27.05.2026",
      "source": "BSE"
    },
    {
      "caption": "Compliances - Regulation 32 (1) And (3) - Statament Of Deviation & Variation Report - March 2026",
      "datetime": "28-May-2026",
      "details": "Statement of Deviation & Variation Report - March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Corporate Action-Board to consider Dividend",
      "datetime": "28-May-2026",
      "details": "The Board of Directors of the comoany at the meeting held on Wednesday May 27 2026 recommnded payment of Final Dividend of Rs. 1.00 per Equity Share of the face value of Rs. 10.00 each for the financial year ended March 31 2026 subject to approval of the shareholders at the ensuing Annual General Meeting of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Medicamen Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News